Myocardial ischaemia in children with sickle cell disease

Archives of Disease in Childhood

Volumn 89, Issue 4, 2004, Pages 359-362

  De Montalembert, M ^a   Maunoury, C ^a   Acar, P ^b   Brousse, V ^a   Sidi, D ^b   Lenoir, G ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Service de Cardialogie Pediatrique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; THALLIUM 201;

ADOLESCENT; ADULT; ANGINA PECTORIS; ARTICLE; BONE; BRAIN; CHILD; CLINICAL ARTICLE; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SIZE; HUMAN; HYPOKINESIA; MALE; PRIORITY JOURNAL; RISK FACTOR; SICKLE CELL ANEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; THORAX PAIN; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, STRESS; HUMANS; MYOCARDIAL ISCHEMIA; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1942445296     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.027326     Document Type: Article

References (21)

1. Covitz W. Cardiac disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994:725-34.
2. Uzsoy NK. Cardiovascular findings in patients with sickle cell anemia. Am J Cardiol 1964;13:320-8.
3. Oliveira E, Gomez-Patino N. Falcemic cardiomyopathy. Am J Cardiol 1963;11:686-8.
4. Gerry JL, Bulkley BH, Hutchins GM. Clinicopathological analysis of cardiac dysfunction in 52 patients with sickle cell anemia. Am J Cardiol 1978;42:211-16.
5. Rubler S, Altman Fleischer R. Sickle cell states and cardiomyopathy. Am J Cardiol 1967;19:867-73.
6. Martin C, Cobb C, Johnson C, et al. Cardiovascular pathology in sickle cell disease. J Am Coll Cardiol 1983;1:723.
7. Lester LA, Sodt PC, Hutcheon N, et al. Cardiac abnormalities in children with sickle cell anemia. Chest 1990;98:1169-74.
8. De Pontual L, Acar P, de Montalembert M, et al. L'ischémie myocardique: une complication méconnue de la drépanocytose de l'enfant. A propos de 2 observations. Arch Pédiatr 1999;6:178-81.
9. Mansi IA, Rosner F. Myocardial infarction in sickle cell disease. J Natl Med Assoc 2002;94:448-52.
10. Norris S, Johnson CS, Julian Haywood L. Sickle cell anemia: does myocardial ischemia occur during crisis? J Natl Med Assoc 1991;83:209-13.
11. James TN. Homage to James B. Herrick. A contemporary look at myocardial infarction and at sickle cell heart disease. Circulation 2000;101:1874-87.
12. Martin CR, Johnson CS, Cobb C, et al. Myocardial infarction in sickle cell disease. J Natl Med Assoc 1996;88:428-32.
13. Covitz W, Espeland M, Gallagher D, et al. The heart in sickle cell anemia. The cooperative study of sickle cell disease (CSSCD). Chest 1995;108:1214-19.
14. Rees AH, Stefadouros MA, Strong WB, et al. Left ventricular performance in children with homozygous sickle cell anaemia. Br Heart J 1978;40:690-6.
15. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
16. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I:II trial. Blood 1999;94:1550-4.
17. De Mantalembert M, Bégué P, Bernaudin F, et al. Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. Arch Dis Child 1999;81:437-9.
18. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001;97:3628-32.
19. Styles LA, Lubin B, Vichinsky E, et al. Decrease of very late activation antigen-4 and CD 36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997;89:2554-9.
20. Gladwin MT, Shelhamer JH, Ognibene FP, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol 2002;116:436-44.
21. De Montalembert M, Davies SC. Is hydroxyurea leukemogenic in children with sickle cell disease? Blood 2001;98:2878-9.